Abacavir/Lamivudine Versus Tenofovir DF/Emtricitabine as Part of Combination Regimens for Initial Treatment of HIV: Final Results-Reference-Cited by-同舟云学术

Abacavir/Lamivudine Versus Tenofovir DF/Emtricitabine as Part of Combination Regimens for Initial Treatment of HIV: Final Results

Published:2011-10-15 Issue:8 Volume:204 Page:1191-1201
ISSN:1537-6613
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Sax Paul E.,Tierney Camlin,Collier Ann C.,Daar Eric S.,Mollan Katie,Budhathoki Chakra,Godfrey Catherine,Jahed Nasreen C.,Myers Laurie,Katzenstein David,Farajallah Awny,Rooney James F.,Ha Belinda,Woodward William C.,Feinberg Judith,Tashima Karen,Murphy Robert L.,Fischl Margaret A.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/204/8/1191/18065465/jir505.pdf

Reference17 articles.

1. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel;Thompson;JAMA,2010

2. Abacavir versus zidovudine combined with lamivudine and efavirenz, for the treatment of antiretroviral-naive HIV-infected adults;DeJesus;Clin Infect Dis,2004

3. Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV;Gallant;N Engl J Med,2006

4. Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV therapy;Sax;N Engl J Med,2009

Cited by 153 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An injectable in situ crosslinkable platform for ultra-long-acting delivery of hydrophilic therapeutics;2023-11-05

2. First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children: A Substudy of the CHAPAS-4 Trial;Clinical Infectious Diseases;2023-05-09

3. BHIVA guidelines on antiretroviral treatment for adults living with HIV‐1 2022;HIV Medicine;2022-12

4. Antiretroviral therapy resistance mutations among HIV infected people in Kazakhstan;Scientific Reports;2022-10-13

5. Prevalence and Structure of HIV-1 Drug Resistance to Antiretrovirals in the Volga Federal District in 2008–2019;Viruses;2022-08-27